1. Home
  2. WOLF vs EVO Comparison

WOLF vs EVO Comparison

Compare WOLF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

HOLD

Current Price

$17.41

Market Cap

838.3M

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.16

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOLF
EVO
Founded
1987
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
838.3M
1.1B
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
WOLF
EVO
Price
$17.41
$3.16
Analyst Decision
Hold
Strong Buy
Analyst Count
7
1
Target Price
$10.50
$7.00
AVG Volume (30 Days)
1.2M
253.9K
Earning Date
01-28-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$759,700,000.00
$887,396,457.00
Revenue This Year
$8.53
N/A
Revenue Next Year
N/A
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.05
$2.84
52 Week High
$36.60
$4.80

Technical Indicators

Market Signals
Indicator
WOLF
EVO
Relative Strength Index (RSI) 39.88 51.07
Support Level $17.19 $3.03
Resistance Level $18.63 $3.18
Average True Range (ATR) 1.03 0.08
MACD -0.12 0.04
Stochastic Oscillator 7.53 85.48

Price Performance

Historical Comparison
WOLF
EVO

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: